Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Early First-Line Bortezomib for Acute Antibody-Mediated Rejection: A Retrospective Review of Long-Term Outcomes From a Uniform Single-Center Protocol.

BACKGROUND Antibody-mediated rejection (ABMR) is a major complication of kidney transplantation. With the current standard of care, long-term graft survival is poor. Optimal treatment remains uncertain, and various protocols are being used. Bortezomib has been previously proposed as a candidate for ABMR treatment, but...

K. Tzukert, Roy Abel, Gil Benedek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.